12 results

• Omnipod Recall Impacts Another 7 Million Defective Pods That May Cause DKA, Hospitalization

  May 27, 2026

  Michael Adams

  Federal regulators have expanded an Omnipod recall after reports that internal tubing defects may cause insulin leaks and under-delivery, potentially triggering dangerous blood sugar spikes.

• Recalled Omnipod 5 Injuries Skyrocket, Prompting Removal of Insulin Pump Pods

  April 30, 2026

  Michael Adams

  Insulet is removing certain Omnipod 5 insulin pump pods from use following a surge in reports of insulin delivery failures that raise risks of diabetic ketoacidosis and other serious complications.

• Tandem Mobi Insulin Pump Recall Issued Following Multiple Serious Injuries

  April 23, 2026

  Martha Garcia

  The FDA has decided that a Tandem Mobi insulin pump device correction should be considered a Class I recall following multiple reports of serious patient injuries.

• Medtronic MiniMed Infusion Pump Recall Issued Over Risk of Hypo- or Hyperglycemic Reactions

  April 7, 2026

  Darian Hauf

  Federal health officials have announced a recall impacting more than half a million Medtronic MiniMed insulin pumps after the manufacturer identified a design flaw that may cause the devices to deliver too little or too much insulin.

• Medtronic Insulin Pump Air Pressure Issues Could Lead to Dangerously Low Blood Sugar Levels

  March 6, 2025

  Darian Hauf

  A medical device correction was issued by the manufacturer after identifying a design flaw that could lead to the insulin pumps malfunctioning during airplane flights.

• Vision Problems From Ozempic, Other GLP-1 Drugs May Result From Rapid Correction of Hyperglycemia: Study

  February 6, 2025

  Irvin Jackson

  A new study raises questions about whether Ozempic vision loss is caused by toxic ingredients in the drug, or the body's reaction to quickly dropping blood sugar levels.

• Medtronic MiniMed Insulin Pump Recall Over Battery Failure Risks

  October 7, 2024

  Irvin Jackson

  FDA has announced a class I recall impacting tens of thousands of Medtronic MiniMed insulin pumps, due to risks that the battery may deplete rapidly after the device has been dropped or physically impacted.

• Case Study Links Tepezza Side Effects to a Potential Risks for Diabetics

  October 4, 2023

  Irvin Jackson

  Tepezza side effects may cause a loss of glycemic control and increased risk of diabetic ketoacidosis, according to the findings of a new study.

• Tepezza Side Effects May Increase Risk of Hyperglycemia: Study

  November 29, 2022

  Irvin Jackson

  A new study found more than half of patients who took Tepezza experienced some form of hyperglycemia, which could be a particularly serious risk to patients with diabetes.

• Class Action Lawsuit Over Medtronic MiniMed Insulin Pumps Filed in Canada

  November 4, 2021

  Irvin Jackson

  Medtronic now faces a class action lawsuit in Canada over problems with its MiniMed 600 series insulin pumps, which have been subject to various recalls in recent years due to over- or underdelivering life-saving insulin.